评估上市后药品安全性方面一个未得到充分认识的挑战。 - Suppr

Suppr

超能文献

An underrecognized challenge in evaluating postmarketing drug safety.

作者信息

Roden Dan M

出版信息

Circulation. 2005 Jan 25;111(3):246-8. doi: 10.1161/01.CIR.0000154578.45378.8C.

DOI:10.1161/01.CIR.0000154578.45378.8C

PMID:15668350

Abstract

摘要

相似文献

An underrecognized challenge in evaluating postmarketing drug safety.

Circulation. 2005 Jan 25;111(3):246-8. doi: 10.1161/01.CIR.0000154578.45378.8C.

FDA attempting to overcome major roadblocks in monitoring drug safety.

J Natl Cancer Inst. 2005 Jun 15;97(12):872-3. doi: 10.1093/jnci/97.12.872.

Decision support methods for the detection of adverse events in post-marketing data.

Drug Discov Today. 2009 Apr;14(7-8):343-57. doi: 10.1016/j.drudis.2008.12.012. Epub 2009 Jan 31.

How should we react to adverse drug reactions?

Postgrad Med J. 2011 Feb;87(1024):81-2. doi: 10.1136/pgmj.2010.105064.

Strategy for surveillance of adverse drug events.

Food Drug Law J. 2007;62(3):605-16.

[Detection of side effects. 2: Responsibilities of the pharmaceutical industry, drug commissions, the Federal Health Office and international organizations].

Fortschr Med. 1991 Jul 20;109(21):429-31.

Safety in numbers--monitoring risk in approved drugs.

N Engl J Med. 2005 Mar 24;352(12):1173-6. doi: 10.1056/NEJMp058029.

Pharmacovigilance in India: how safe are the new drugs? How sure are we?

J Assoc Physicians India. 2008 Dec;56:933-4.

The US drug safety system: role of the pharmaceutical industry.

Pharmacoepidemiol Drug Saf. 2008 Feb;17(2):110-4. doi: 10.1002/pds.1467.

Advantages of adverse-effect reporting by patients.

Prescrire Int. 2011 Mar;20(114):70.

引用本文的文献

A new hERG allosteric modulator rescues genetic and drug-induced long-QT syndrome phenotypes in cardiomyocytes from isogenic pairs of patient induced pluripotent stem cells.

EMBO Mol Med. 2016 Sep 1;8(9):1065-81. doi: 10.15252/emmm.201606260. Print 2016 Sep.

Genetics of congenital and drug-induced long QT syndromes: current evidence and future research perspectives.

J Interv Card Electrophysiol. 2013 Jun;37(1):9-19. doi: 10.1007/s10840-013-9779-5. Epub 2013 Mar 21.

Observational therapeutics: Scope, challenges, and organization.

J Ayurveda Integr Med. 2011 Oct;2(4):165-9. doi: 10.4103/0975-9476.90764.

Drug-induced long QT syndrome.

Pharmacol Rev. 2010 Dec;62(4):760-81. doi: 10.1124/pr.110.003723.

Pharmacoepidemiology of QT-interval prolonging drug administration in critically ill patients.

Pharmacoepidemiol Drug Saf. 2008 Oct;17(10):971-81. doi: 10.1002/pds.1637.

Cellular basis of drug-induced torsades de pointes.

Br J Pharmacol. 2008 Aug;154(7):1502-7. doi: 10.1038/bjp.2008.238. Epub 2008 Jun 16.

Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges.

Nat Rev Drug Discov. 2007 Nov;6(11):904-16. doi: 10.1038/nrd2423.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验